Enables biopharma catalyst research by aggregating signals from ClinicalTrials.gov, PubMed, SEC EDGAR, openFDA, and Yahoo Finance, with a single tool to audit a ticker/drug combination and return a forensic verdict.
Provides read-only, provenance-first repository navigation for agents and humans, with ranked lexical retrieval, exact query, document handles, symbol context, and change impact analysis.
Enables querying and analyzing changes in technology company documentation through MCP tools, including change feeds, company info, and evidence-based messaging.
Enables read-only access to Addepar portfolio and ownership data for financial reporting, with transparent provenance caveats and compliance-oriented audit logging.
